[HTML][HTML] Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function …
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC Cardiovascular …, 2021 - europepmc.org
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC …, 2021 - scholarworks.bwise.kr
Background: Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC Cardiovascular …, 2021 - search.proquest.com
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
[HTML][HTML] Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function …
KH Kim, BG Choi, SW Rha… - BMC …, 2021 - bmccardiovascdisord.biomedcentral …
Patients with acute myocardial infarction (AMI) are usually treated with angiotensin-
converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) if ACEIs are …
converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) if ACEIs are …
[HTML][HTML] Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC Cardiovascular …, 2021 - ncbi.nlm.nih.gov
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC …, 2021 - scholar.korea.ac.kr
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha… - BMC cardiovascular …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi… - BMC …, 2021 - search.ebscohost.com
Abstract < bold> Background: </bold> Patients with acute myocardial infarction
(AMI) are usually treated with angiotensin-converting enzyme inhibitors (ACEIs), or …
(AMI) are usually treated with angiotensin-converting enzyme inhibitors (ACEIs), or …
Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a …
KH Kim, BG Choi, SW Rha, CU Choi, MH Jeong… - 2021 - scholarworks.gnu.ac.kr
Background: Patients with acute myocardial infarction (AMI) are usually treated with
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) …